Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 23;59(1):32.
doi: 10.3390/medicina59010032.

The Dynamics of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict Progression to Septic Shock and Death in Patients with Prolonged Intensive Care Unit Stay

Affiliations

The Dynamics of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict Progression to Septic Shock and Death in Patients with Prolonged Intensive Care Unit Stay

Ioana Denisa Botoș et al. Medicina (Kaunas). .

Abstract

Background and objectives: The prognoses of patients experiencing a prolonged stay in the intensive care unit (ICU) are often significantly altered by hospital-acquired infections (HAIs), the early detection of which might be cumbersome. The aim of this study was to investigate the roles of the neutrophil-to-lymphocyte (NLR), derived-NRL (d-NLR), platelet-to-lymphocyte (PLR), and lymphocyte-to-C-reactive protein (LCR) ratios in predicting the progression to septic shock and death. Materials and Methods: A retrospective analysis of a consecutive series of ninety COVID-19 patients with prolonged hospitalization (exceeding 15 days) admitted to the ICU was conducted. The prevalence of culture-proven HAIs throughout their hospital stays was documented. NLR, dNLR, PLR, and LCR were recorded on admission, day 7, and day 14 to assess their discriminative prowess for detecting further progression to septic shock or death. Results: The prevalence of HAIs was 76.6%, 50% of patients met the criteria for septic shock, and 50% died. The median time to the first positive culture was 13.5 days and 20.5 days for developing septic shock. Mechanical ventilation was a key contributing factor to HAI, septic shock, and mortality. On admission and day 7 NLR, dNLR, PLR, and LCR values had no prognostic relevance for events occurring late during hospitalization. However, day-14 NLR, dNLR, and PLR were independent predictors for progression to septic shock and mortality and have shown good discriminative capabilities. The AUCs for septic shock were 0.762, 0.764, and 0.716, while the values for predicting in-hospital death were 0.782, 0.778, and 0.758, respectively. Conclusions: NLR, dNLR, and PLR are quick, easy-to-use, cheap, effective biomarkers for the detection of a more severe disease course, of the late development of HAIs, and of the risk of death in critically ill patients requiring a prolonged ICU stay.

Keywords: hospital-acquired infections; intensive care; neutrophil-to-lymphocyte ratio; platelet-to-lymphocyte ratio; sepsis; septic shock.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study, the collection, analyses, or interpretation of data, the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Time-dependent variation in the values of the hematological biomarkers on admission, at day 7, and at day 14.
Figure 2
Figure 2
Area under the receiver-operating characteristic curve analysis for discriminating progression towards septic shock (left) and in-hospital mortality (right) for the neutrophil-to-lymphocyte ratio, derived neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio.

References

    1. Mielke N., Johnson S., Bahl A. Boosters Reduce In-Hospital Mortality in Patients with COVID-19: An Observational Cohort Analysis. Lancet Reg. Health-Am. 2022;8:100227. doi: 10.1016/j.lana.2022.100227. - DOI - PMC - PubMed
    1. Bechman K., Yates M., Mann K., Nagra D., Smith L.J., Rutherford A.I., Patel A., Periselneris J., Walder D., Dobson R.J.B., et al. Inpatient COVID-19 Mortality Has Reduced over Time: Results from an Observational Cohort. PLoS ONE. 2022;17:e0261142. doi: 10.1371/journal.pone.0261142. - DOI - PMC - PubMed
    1. Huang Y.Z., Kuan C.C. Vaccination to Reduce Severe COVID-19 and Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis. Eur. Rev. Med. Pharmacol. Sci. 2022;26:1770–1776. doi: 10.26355/eurrev_202203_28248. - DOI - PubMed
    1. Hou C., Hu Y., Yang H., Chen W., Zeng Y., Ying Z., Hu Y., Sun Y., Qu Y., Gottfreðsson M., et al. COVID-19 and Risk of Subsequent Life-Threatening Secondary Infections: A Matched Cohort Study in UK Biobank. BMC Med. 2021;19:1–10. doi: 10.1186/s12916-021-02177-0. - DOI - PMC - PubMed
    1. Elabbadi A., Turpin M., Gerotziafas G.T., Teulier M., Voiriot G., Fartoukh M. Bacterial Coinfection in Critically Ill COVID-19 Patients with Severe Pneumonia. Infection. 2021;49:559–562. doi: 10.1007/s15010-020-01553-x. - DOI - PMC - PubMed